Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $92.7752W HIGH $127.99
Volume
604.38 K
Value Traded
172.85 M
Short % Float
3.07%
+1.95%Week
+1.89%1 Month
+12.08%3 Month
+14.66%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
12.17 B
EPS (TTM)
6.29
P/E Ratio
19.59
Ent. Value
12.06 B
Total Shares
98.65 M
Float Shares
97.65 M
Insiders
1.01%
Institutions
98.09%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
EHC Catalyst Timeline
Dated clinical, regulatory and corporate events for Encompass Health Corporation Common Stock
Past FDA Catalysts and PDUFA Decisions
How EHC actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Encompass Health Corporation is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every EHC program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Price Andrew LOfficer (Chief Accounting Officer) | Sell | -5,211 69,483 held | $120.93 | 08/31/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in EHC
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| Avidity Partners | 0.7 % (-30 %) | 4.25 M | 42.00 K |
EHC Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How EHC ranks across every disease it competes in
Competitive Position is a premium feature
See how EHC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialEHC News
-EHC
Oct 6, 2026Encompass Health Rehabilitation Hospital of Bangor now open in Maine
Encompass Health has opened a new 50-bed rehabilitation hospital in Bangor, Maine, aimed at providing essential rehabilitation services. The facility will assist patients recovering from various serious conditions, offering intensive therapy and personalized care. This opening is expected to improve access to high-quality rehabilitation in the Northeast and relieve pressure on local acute care hospitals.
Read more →-EHC
Oct 1, 2026Encompass Health announces date of 2026 third-quarter earnings call
Encompass Health Corp. has announced its third-quarter earnings call for 2026, scheduled for October 29. The company will report its financial results after the market closes on October 28. Interested parties can join the call via phone or access a live webcast on the company's investor website.
Read more →-EHC
Sep 24, 2026Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospital
Encompass Health Corp. announced plans to expand its rehabilitation services in Montgomery County, Texas, with a new small-format hospital in Conroe and a replacement hospital in The Woodlands. The Conroe facility will enhance access to specialized care, while the replacement hospital aims to improve patient experience with modern amenities. Both projects reflect the company's commitment to growth and community service.
Read more →-EHC
Sep 15, 2026Encompass Health Rehabilitation Hospital of Lower Providence now open in Pennsylvania
Encompass Health has opened a new rehabilitation hospital in Lower Providence Township, Pennsylvania. This facility, which has a capacity of 50 beds, is now accepting patients. As the largest operator of inpatient rehabilitation hospitals in the U.S., Encompass Health continues to expand its services in the region.
Read more →-EHC
Aug 10, 2026Encompass Health prices private offering of additional 5.875% senior notes due 2034
Encompass Health Corp. has announced the pricing of an additional $100 million in 5.875% senior notes due 2034. This offering will be a reopening of previously issued notes and is expected to close on August 13, 2026. The proceeds will be used to repay amounts under the company's senior secured revolving credit facility.
Read more →-EHC
Aug 10, 2026Encompass Health announces launch of private offering of 5.875% senior notes due 2034
Encompass Health Corp. has announced a private offering of $100 million in additional 5.875% senior notes due 2034. This offering aims to refinance existing debt under its senior secured revolving credit facility. The notes will be available to qualified institutional buyers and certain non-U.S. persons, and are not registered under the Securities Act.
Read more →-EHC
Aug 5, 2026▲ +12.6%on this newsshared move
Encompass Health reports results for second quarter 2026
Encompass Health Corporation reported strong second-quarter results for 2026, with a 9.6% increase in net operating revenue and a 9.2% rise in adjusted EBITDA. The company has raised its full-year guidance, anticipating further growth through the opening of additional hospitals. Despite some challenges, including a decrease in adjusted free cash flow, the overall outlook remains optimistic.
Read more →-EHC
Jul 23, 2026Encompass Health increases and declares dividend on common stock
Encompass Health Corp. announced a $0.02 increase in its quarterly dividend, raising it to $0.21 per share. The dividend is payable on October 15, 2026, to shareholders on record as of October 1, 2026. The company is recognized for its leadership in inpatient rehabilitation with a significant national footprint.
Read more →-EHC
Jul 9, 2026Encompass Health announces date of 2026 second quarter earnings call
Encompass Health Corp. has announced its second quarter earnings call for 2026, scheduled for August 6, 2026. The company will report its results after market close on August 5, 2026. Investors can access the call via phone or through a live webcast on the company's investor website.
Read more →-EHC
May 29, 2026Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
Encompass Health Corp. plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, relocating from its former 19-bed unit. The new facility will enhance access to rehabilitation services, featuring private rooms and advanced therapy equipment. The hospital aims to serve patients recovering from serious conditions, including strokes and orthopedic issues.
Read more →-EHC
May 14, 2026Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Encompass Health Corp. announced the redemption of $400 million of its 4.500% senior notes due 2028, set for June 13, 2026. The company anticipates a $3.2 million loss on this early debt extinguishment. The total outstanding principal of these notes was $800 million as of May 14, 2026.
Read more →-EHC
May 14, 2026Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
Encompass Health Corp. has announced the pricing of a private offering of $500 million in senior notes due 2034, with a 5.875% interest rate. The company plans to use the proceeds to redeem existing notes and repay part of its revolving credit facility. The offering is expected to close on May 29, 2026, pending customary conditions.
Read more →-EHC
May 14, 2026Encompass Health announces private offering of senior notes
Encompass Health Corp. has announced a private offering of $500 million in senior notes maturing in 2034. The proceeds will be used to redeem $400 million of existing senior notes due 2028 and repay $100 million of its revolving credit facility. The offering is targeted at qualified institutional buyers and is subject to market conditions.
Read more →-EHC
May 11, 2026Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho
Encompass Health Corp. plans to construct a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho, aimed at serving patients recovering from serious illnesses and injuries. The facility will offer specialized therapies and advanced rehabilitation technology. Expected to open in 2028, it will expand the company's presence in Idaho, addressing the growing need for rehabilitation services in the region.
Read more →-EHC
May 7, 2026Encompass Health declares dividend on common stock
Encompass Health Corp. has announced a quarterly cash dividend of $0.19 per share, payable on July 15, 2026. This decision reflects the company's strong financial position and commitment to returning value to shareholders. Encompass Health is a prominent operator of inpatient rehabilitation hospitals across the U.S., recognized for its quality care and innovative treatments.
Read more →-EHC
Apr 23, 2026Encompass Health to participate in BofA Securities 2026 Health Care Conference
Encompass Health Corp. will participate in the BofA Securities 2026 Health Care Conference from May 12-14, 2026. CFO Doug Coltharp will engage in a fireside chat on May 12, 2026, which will be available via live webcast. The company is noted for its leadership in inpatient rehabilitation care across the U.S.
Read more →-EHC
Apr 22, 2026Encompass Health and Cookeville Regional Medical Center announce plans to build a 40-bed inpatient rehabilitation hospital in Cookeville, Tennessee
Encompass Health and Cookeville Regional Medical Center are collaborating to establish a 40-bed inpatient rehabilitation hospital in Cookeville, Tennessee. This facility aims to meet the increasing demand for rehabilitation services in the region, providing specialized care for patients recovering from various conditions. The hospital is expected to open in 2027, featuring private rooms and advanced therapy technologies.
Read more →-EHC
Sep 9, 2019Hillary Carnel | 205 970-5912 hillary.carnel@encompasshealth.com Investor Relations Contact: Crissy Carlisle | 205 970-5860 crissy.carlisle@encompasshealth.com Encompass Health prices offering of its 4.500
Hillary Carnel | 205 970-5912 hillary.carnel@encompasshealth.com Crissy Carlisle | 205 970-5860 crissy.carlisle@encompasshealth.com Health prices offering of its 4.500% senior notes due 2028 and its 4.750% senior notes due 2030 BIRMINGHAM, Ala., Sept. 9, 2019 Encompass Heal
Read more →-EHC
Apr 1, 2019Encompass Health Contacts: Media: Hillary Carnel, 205 970-5912 hillary.carnel@encompasshealth.com Investor Relations: Crissy Carlisle, 205 970-5860 crissy.carlisle@encompasshealth.com Encompass Health announces definitiv
Encompass Health Contacts: Media: Hillary Carnel, 205 970-5912 hillary.carnel@encompasshealth.com Investor Relations: Crissy Carlisle, 205 970-5860 crissy.carlisle@encompasshealth.com Encompass Health announces definitive agreement to acquire Birmingham based Alacare Home Health
Read more →About Encompass Health Corporation Common Stock
Headquarters9001 LIBERTY PARKWAY, BIRMINGHAM, AL, 35242
BIOPHARMAWATCH ELITE PLUS
Trade the next EHC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime